Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2

Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras

Steven P. Luckman, D. E. Hughes, Fraser P. Coxon et al. · Journal of Bone and Mineral Research · 1998 · 1.2K citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation <i>in vitro</i>

John Fisher, Michael J. Rogers, J. M. Halasy et al. · Proceedings of the National Academy of Sciences · 1999 · 679 citations

Medicine, Biochemistry, Pharmacology +17

Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by Receptor Activator of NF-κB Ligand (RANKL)

Masahito Matsumoto, T Sudo, Tamio Saito et al. · Journal of Biological Chemistry · 2000 · 508 citations · Full text

Life Sciences, Cell Biology, Pharmacology +16

Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.

Mohan Singh Sahni, Harald L. Guenther, H. Fleisch et al. · Journal of Clinical Investigation · 1993 · 415 citations · Full text

Medicine, Chemical Biology, Bone Augmentation +16

U0126 and PD98059, Specific Inhibitors of MEK, Accelerate Differentiation of RAW264.7 Cells into Osteoclast-like Cells

Hitoshi Hotokezaka, Eiko Sakai, Kazuhiro Kanaoka et al. · Journal of Biological Chemistry · 2002 · 319 citations · Full text

Medicine, Cell Biology, Pharmacology +14